Conclusion: urinary NMP22 is a very specific, sensitive tumor marker for the diagnosis of bladder cancers and can indicate tumor's malignancy degree and prognosis.
结论：尿nmp22作为膀胱癌的肿瘤标记物具有较高的特异性和敏感性，并可在一定程度上反映肿瘤的恶性程度和预后。
Purpose: to evaluate primarily the ability of urinary level of nuclear matrix protein 22 (NMP22) as a tumor marker for the diagnosis of original and recurrent bladder cancer.
目的：评估尿核基蛋白(NMP22)测定作为诊断初发性膀胱癌及复发性膀胱癌的临床应用价值。
Bladder cancer is the most popular malignant tumor in urinary system and transitional cell carcinoma (TCC) is the most common pathological type of it.
膀胱癌是泌尿系统最常见的恶性肿瘤之一，移行细胞癌(TCC)是其最常见病理类型。
应用推荐